Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-MSU – Stopping haemorrhage with tranexamic acid for hyperacute intracerebral haemorrhage including Mobile Stroke Units
2020-004746-10Phase 2Completed
- Sponsor
- Florey Institute of Neuroscience and Mental Health
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in intracerebral hemorrhage (ICH) comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Haematoma growth at 24±6 hours. Started Nov 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2020-004746-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004746-10.